Component information
Different name of ingredient
- Larotrectinibum
- (3S)-N-{5-[(2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl}-3-hydroxypyrrolidine-1-carboxamide
- LOXO-101
- (3S)-N-{5-[(2R)-2-(2,5-Difluorphenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl}-3-hydroxypyrrolidin-1-carbamid
- Larotrectinib
Alternative medicine with selected ingredient
| Name | PZN | Form | Packing | Manufacturer | Price | |
|---|---|---|---|---|---|---|
| Details | VITRAKVI 100 mg Hartkapseln | P15024331 | HKP | 56 St | BAYPH | € 5420.30 |
| Details | VITRAKVI 25 mg Hartkapseln | P15024325 | HKP | 56 St | BAYPH | € 1394.20 |
| Details | VITRAKVI 20 mg/ml Lösung zum Einnehmen | P16768447 | LSE | 2X50 ml | BAYPH | € 1972.88 |
| Details | VITRAKVI 100 mg Hartkapseln | P18059666 | HKP | 56 St | KOHL | € 5413.83 |